These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31034608)

  • 1. Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema.
    Fernandez-Santamaría R; Palomares F; Salas M; Doña I; Bogas G; Ariza A; Rodriguez-Nogales A; Plaza-Seron MC; Mayorga C; Torres MJ; Fernández TD
    Allergy; 2019 Sep; 74(9):1769-1779. PubMed ID: 31034608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients.
    Li X; Chen Y; Liu X; Zhang J; He X; Teng G; Yu D
    Int Immunopharmacol; 2017 Mar; 44():153-159. PubMed ID: 28103502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
    Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
    FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Tim‑3 and Gal‑9 expression and gastric cancer prognosis.
    Wang Y; Zhao E; Zhang Z; Zhao G; Cao H
    Oncol Rep; 2018 Oct; 40(4):2115-2126. PubMed ID: 30106451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis.
    Kang J; Wei ZF; Li MX; Wang JH
    J Biosci; 2020; 45():. PubMed ID: 32345786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.
    Kandel S; Adhikary P; Li G; Cheng K
    Cancer Lett; 2021 Jul; 510():67-78. PubMed ID: 33895262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim3 binding to galectin-9 stimulates antimicrobial immunity.
    Jayaraman P; Sada-Ovalle I; Beladi S; Anderson AC; Dardalhon V; Hotta C; Kuchroo VK; Behar SM
    J Exp Med; 2010 Oct; 207(11):2343-54. PubMed ID: 20937702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological implications of TIM3
    Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
    Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
    Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the Peptide-TIM3 Binding Site in Inhibiting TIM3-Galectin 9 Binding Pathways.
    Odstrcil RE; Dutta P; Liu J
    J Chem Theory Comput; 2023 Sep; 19(18):6500-6509. PubMed ID: 37649156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
    Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
    Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway.
    Luo LH; Li DM; Wang YL; Wang K; Gao LX; Li S; Yang JG; Li CL; Feng W; Guo H
    Biochem Biophys Res Commun; 2017 Sep; 491(4):966-972. PubMed ID: 28756232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis.
    Sada-Ovalle I; Chávez-Galán L; Torre-Bouscoulet L; Nava-Gamiño L; Barrera L; Jayaraman P; Torres-Rojas M; Salazar-Lezama MA; Behar SM
    J Immunol; 2012 Dec; 189(12):5896-902. PubMed ID: 23180819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Tim3-positive T cell subsets in patients with multiple sclerosis.
    Feng X; Feng J
    J Clin Neurosci; 2016 Dec; 34():193-197. PubMed ID: 27544230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated TIM3 expression of T helper cells affects immune system in patients with myelodysplastic syndrome.
    Fu R; Li L; Hu J; Wang Y; Tao J; Liu H; Liu Z; Zhang W
    J Investig Med; 2019 Dec; 67(8):1125-1130. PubMed ID: 31511310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
    J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis.
    Rodríguez-Jiménez P; Chicharro P; Llamas-Velasco M; Cibrian D; Trigo-Torres L; Vara A; Jiménez-Fernández M; Sevilla-Montero J; Calzada MJ; Sánchez-Madrid F; de la Fuente H; Daudén E
    Front Immunol; 2019; 10():1268. PubMed ID: 31214201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells.
    Leskela S; Serrano A; de la Fuente H; Rodríguez-Muñoz A; Ramos-Levi A; Sampedro-Nuñez M; Sánchez-Madrid F; González-Amaro R; Marazuela M
    PLoS One; 2015; 10(4):e0123938. PubMed ID: 25880730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tim3
    Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
    Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
    Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
    Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.